发明名称 LIQUID FORMULATION OF LONG-ACTING INSULIN CONJUGATE
摘要 The present invention relates to a liquid formulation of long-acting insulin conjugate, comprising a pharmaceutically effective amount of a long-acting insulin conjugate, wherein a physiologically active peptide, which is an insulin, is linked to an immunoglobulin Fc region; and an albumin-free stabilizer, wherein the stabilizer comprises a buffer, a sugar alcohol, a non-ionic surfactant, and an isotonic agent, and a method for preparing the formulation. For preventing microbial contamination in multiple uses, a preservative can be added to the formulation. The liquid formulation of the present invention does not comprise a human serum albumin and potentially hazardous factors to body, and thus it has excellent storage stability for insulin conjugate without a risk of viral infection.
申请公布号 US2015196643(A1) 申请公布日期 2015.07.16
申请号 US201314415206 申请日期 2013.07.25
申请人 HANMI PHARM. CO., LTD. 发明人 Lim Hyung Kyu;Kim Hyun Uk;Hong Sung Hee;Kim Min Young;Bae Sung Min;Kwon Se Chang
分类号 A61K47/26;A61K47/10;A61K47/12;A61K47/02;A61K38/28;A61K47/48 主分类号 A61K47/26
代理机构 代理人
主权项 1. A liquid formulation of long-acting insulin conjugate, comprising a pharmaceutically effective amount of a long-acting insulin conjugate, wherein an insulin which is a physiologically active peptide, is linked to an immunoglobulin Fc region; and an albumin-free stabilizer, wherein the stabilizer comprises a buffer, a sugar alcohol, a non-ionic surfactant, and an isotonic agent.
地址 Hwaseong-si, Gyeonggi-do KR